Bone Growth Stimulator Market Analysis

  • Report ID: 4601
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Bone Growth Stimulator Market Analysis

Application (Delayed Union & Non-union Bone Fractures, Spinal Fusion Surgeries, Oral & Maxillofacial Surgeries)

The global bone growth stimulator market is segmented and analyzed for demand and supply by application into delayed union & non-union bone fractures, spinal fusion surgeries, and oral & maxillofacial surgeries. Amongst these segments, the spinal fusion surgeries segment is projected to garner the largest market share over the forecast period. It is backed by the staggering count of patient pools undergoing spinal fusion surgeries throughout the world.Spinal fusion is a surgical procedure to link disconnected spinal bones back together again. A substance similar to bone is inserted between the bones during the process. The bones may then be held together using plates, orthopedic braces, screws, or rods made of inert materials. Eventually, the bones fuse and become one bone to recover. For instance, every year approximately 1.70 million instrumented spinal fusion surgeries are performed in the United States.

End-user (Hospitals, Ambulatory Surgical Centers, Orthopedic Clinics, Home Care)

The global bone growth stimulator market is also segmented and analyzed for demand and supply by end users into ambulatory surgical centers, hospitals, orthopedic clinics, home care, and others. Out of these segments, the hospital’s segment is projected to secure the highest share of the market by the end of 2037. This can be attributed to the fact that hospitals are better-equipped and have the right diagnostic and therapeutic devices available for the treatment of bone injuries and disorders. They also may or may not host a separate department or specialists for orthopedic cases. It was found that there were about 6,100 hospitals in the U.S. in 2022.

Our in-depth analysis of the bone growth stimulator market includes the following segments:

           By Application

  • Delayed Union & Non-Union Bone Fractures
  • Spinal Fusion Surgeries
  • Oral & Maxillofacial Surgeries

            By Product

  • Bone Growth Stimulation Devices
  • Bone Morphogenetic Proteins (BMP)
  • Platelet Rich Plasma

            By End User

  • Ambulatory Surgical Centers
  • Hospitals
  • Orthopedic Clinics
  • Home Care
  • Others
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4601
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of bone growth stimulator is assessed at USD 2.41 billion.

The bone growth stimulator market size was valued at USD 2.29 billion in 2024 and is set to reach USD 5.37 billion by the end of 2037, expanding at around 6.9% CAGR during the forecast period i.e., between 2025-2037. Globally increasing prevalence of musculoskeletal disorders, worldwide spike in diabetes, and growing prevalence of obesity will drive the market growth.

North America industry is likely to dominate largest revenue share by 2037, backed by growing prevalence of several bone disorders along with surge in the demand for osteoarthritis treatment in the region.

The major players in the market include DJO, LLC, Arthrex, Inc., Bioventus LLC, Medtronic plc, Regen Lab SA, Elizur Corporation, Ember Therapeutics, IGEA S.p.A, Ossatec Benelux BV, Smith & Nephew PLC.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample